Evaluation of the Antibody Response against Hepatitis C Virus Infection in Patients on Maintenance Hemodialysis (MHD): A Pilot Study.
Loading...
Date
2014
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Majority of the patients with end stage renal disease (ESRD) are on maintenance hemodialysis
(MHD) in Bangladesh. Dialysis patients are at high risk for contracting blood borne infection
including hepatitis C virus (HCV) infection. The aim of this study was to evaluate the antibody
response of hepatitis C virus infection in patients on MHD by detecting different viral markers
in blood. A total of 88 patients with chronic kidney disease (CKD)were recruited from
BIRDEM and BSMMU during the period from June 2006 to June 2007. Of them 63 patients
on MHD and 25 predialysis patients were taken as cases and controls respectivly. Anti-HCV
antibody were positive in 38% of dialysis patients but none of the controls were positive for
Anti-HCV. When HCV positive MHD patients (38%) were compared to HCV negative MHD
patients (62%), it showed that HCV positive patients had longer duration of dialysis (24±25 vs
9±6 months, p<0.001), increased number blood transfusions (29±34 vs 10±9 units,
p<0.004) and elevated serum alanine aminotransferase level (35±23 vs 20±9 U/L,
p=0.001). Implementing comprehensive infection control program by routine screening of the
CKD patients, safe blood transfusion program, reducing transfusion of blood by use of
erythropoietin and proper disinfection and cleaning of hemodialysis units may reduce the
infection by HCV Virus.
Description
Keywords
Hepatitis C virus, Antibody response, Hemodialysis
Citation
Sultana S, Ali M K , Shaha A K, Khan N N, Husain M A. Evaluation of the Antibody Response against Hepatitis C Virus Infection in Patients on Maintenance Hemodialysis (MHD): A Pilot Study. Bangladesh Journal of Medical Biochemistry. 2014; 7(1): 9-13.